MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 153 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,015,000 | -24.6% | 744,813 | +17.0% | 0.01% | -20.0% |
| Q1 2016 | $5,328,000 | +2413.2% | 636,613 | +3620.1% | 0.01% | – |
| Q2 2015 | $212,000 | -92.7% | 17,113 | -93.3% | 0.00% | -100.0% |
| Q4 2014 | $2,886,000 | +2.3% | 255,413 | -20.5% | 0.01% | -12.5% |
| Q3 2014 | $2,820,000 | -32.1% | 321,213 | -43.6% | 0.01% | -20.0% |
| Q2 2014 | $4,151,000 | – | 569,413 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,100,140 | $25,968,000 | 6.81% |
| Portolan Capital Management | 664,298 | $8,214,000 | 1.15% |
| GARRISON BRADFORD & ASSOCIATES INC | 90,700 | $1,122,000 | 1.10% |
| Opus Point Partners Management, LLC | 72,009 | $890,000 | 0.70% |
| Eagle Ridge Investment Management | 122,500 | $1,515,000 | 0.68% |
| EAM Investors, LLC | 350,410 | $4,333,000 | 0.51% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,881,667 | $60,362,000 | 0.37% |
| Cannell & Co. | 1,051,178 | $12,998,000 | 0.37% |
| Birchview Capital, LP | 42,300 | $523,000 | 0.28% |
| Tekla Capital Management LLC | 567,787 | $7,021,000 | 0.25% |